@article{Abdallah2022, 
author = {Yousri Ben Abdallah and Nabil Belfeki and Timothée Klopfenstein and Souheil Zayet},
title = {Pulmonary cavitary disease due to Mycobacterium xenopi},
year = {2022},
journal = {Infectious Medicine},
volume = {1},
number = {1},
pages = {63-66},
keywords = {Mycobacterium xenopi, Non-tuberculous mycobacteria, COPD, Pulmonary cavitary disease},
url = {https://www.sciopen.com/article/10.1016/j.imj.2021.11.001},
doi = {10.1016/j.imj.2021.11.001},
abstract = {Non-tuberculous mycobacteria are a significant cause of pulmonary infections worldwide and can be clinically challenging. Mycobacterium xenopi (M. xenopi) has a low pathogenicity and usually requires immunosuppression or lung diseases. We describe herein a scarce case of pulmonary cavitary disease attributed to M. xenopi in a 57-year-old Caucasian patient with underlying structural lung disease successfully treated with rifampicin, ethambutol, clarithromycin, and amikacin.}
}